<DOC>
	<DOCNO>NCT02018315</DOCNO>
	<brief_summary>The purpose trial determine alternative energy source impact brain metabolism disorder characterize glucose metabolism failure brain . The central hypothesis test investigation whether circumvent impaired glucose metabolism feasible , safe potentially promise supply anaplerotic precursor metabolism odd-carbon fatty acid enter citric acid cycle ( CAC ) alternative metabolic pathway .</brief_summary>
	<brief_title>Treatment Development Glucose Transporter Type I Deficiency Syndrome ( G1D )</brief_title>
	<detailed_description>Triheptanoin , nutritional supplement long use metabolic disorder also add food cosmetic , use complement diet G1D patient may receive enrollment exception ketogenic diet .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Carbohydrate Metabolism , Inborn Errors</mesh_term>
	<criteria>Male Female Ages 1 month &lt; 21 year age Diagnosed glucose transporter type I deficiency . Age match ( within 1 year ) control diagnose G1D . All subject carry body metal implant incompatible exposure magnetic field Subjects unable tolerate MRI MRS procedure due anxiety Subjects receive oxygen supplementation confine bed stretcher Subjects currently receive ketogenic diet , due high risk seizure recurrence transition ketosis . Patients behaviorally unable hold still image procedure ( rather limited seizure activity ) exclude .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>G1D</keyword>
	<keyword>Glut1 Disorder</keyword>
	<keyword>Glucose Transporter Type 1 Disorder</keyword>
	<keyword>Glucose Transporter Type I Disorder</keyword>
</DOC>